Journal profile · Oncology
Journal of Breast Cancer
ISSN 1738-6756 · eISSN 2092-9900 · Korean Breast Cancer Society · SOUTH KOREA · Quarterly · Founded 2003
Journal of Breast Cancer: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.67; fully open access; APC about USD 500; median 129 days to acceptance (76 articles, last 24 months); community-reported acceptance: easy; 45 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Breast Cancer is published by Korean Breast Cancer Society and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Breast Cancer Treatment Studies, Breast Lesions and Carcinomas and Breast Implant and Reconstruction, together about 46.6% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Breast Cancer (abbreviated as ‘J Breast Cancer’) is the official journal of the Korean Breast Cancer Society since 1998. The Journal is issued on the last day of February, April, June, August, October and December each year. All the contents of the Journal is available online at the official journal website (https://ejbc.kr) under open access policy. The Journal aims to provide a forum for the academic communication between medical doctors, basic science researchers, and health care professionals to be interested in breast cancer. To get this aim, we publish original investigations, review articles, brief communications including case reports, editorial opinions on the topics of importance to breast cancer, and welcome new research findings and epidemiological studies, especially when they contain a regional data to grab the international reader's interest. Although the Journal is mainly dealing with the issues of breast cancer, rare cases among benign breast diseases or evidence-based scientifically written articles providing useful information for clinical practice can be published as well. The Journal of Breast Cancer (JBC) is indexed/tracked/covered by Science Citation Index Expanded (SCIE), Scopus, Embase, PubMed, PubMed Central, CrossRef, KoreaMed, Synapse, KCI, KoMCI and Google Scholar. ·
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Hyeong-Gon Moon SeoulPublisher website
Editorial board by country: none in mainland China; most named South Korea 49, Japan 2, United States 1 (52 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology24.8%
- Breast Lesions and CarcinomasMedicine14.9%
- Breast Implant and ReconstructionMedicine7%
- HER2/EGFR in Cancer ResearchMedicine5.4%
- Cancer and Skin LesionsMedicine4.5%
- Cancer Risks and FactorsMedicine4.2%
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology3.6%
- Cancer Treatment and PharmacologyMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPubMedEmbasePublisher website
Other: Google Scholar, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.67LetPub ·
- Impact factor (publisher) 2024
- 2.4Publisher website ·
- 5-year impact factor (publisher)
- 2Publisher website ·
- CiteScore 2026-06
- 4.7LetPub ·
- SJR 2026-06
- 0.89LetPub ·
- SNIP 2026-06
- 1.1LetPub ·
- h-index
- 29LetPub ·
- h-index
- 64OpenAlex ·
- i10-index
- 543OpenAlex ·
- 2-year mean citedness
- 2.21OpenAlex ·
- Self-citation rate
- 2.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 39LetPub ·
Articles by year OpenAlex count · 1,456 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 31 | 31 | 9 |
| 2025 | 45 | 45 | 85 |
| 2024 | 34 | 34 | 149 |
| 2023 | 53 | 53 | 766 |
| 2022 | 50 | 50 | 391 |
| 2021 | 53 | 53 | 681 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
129 daysMedian, submission to acceptance · P25–P75 93 days – 163 days
- Acceptance to online
- median 27 days (76 articles)
- Submission to online
- median 156 days
- Sample
- 76 articles with submission and acceptance dates (77 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 37 daysPublisher website ·
- Submission to acceptance
- 127 daysPublisher website ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 500 | No | CC BY-NC | |
| OpenAlex | USD 500 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- ≤ 5
- Manuscript length
- ≤ 4,000 words
- First submission
- Free format: the journal's layout is not required
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review
- Authorship 2. Authorship
As a general guideline, listed authors should have contributed substantially to (a) the conception and design of the study, generation of the data, or analysis and interpretation of the data and (b) drafting the manuscript or revising it for important scientific content and should have approved the final version of the article submitted for publication. JBC also requires that all authors personall…
Source ↗Publisher website ·- Conflicts of interest 4. Conflicts of Interest
All authors are required to report potential conflicts of interest at the time of initial submission and should mentioned any such conflicts on the title page (see below). Conflicts of interest include all financial or non-financial competing interest that may have influenced or may be perceived to have influenced the author(s)’ interpretation or presentation of the findings. This includes any fin…
Source ↗Publisher website ·- Data availability 6. Data Sharing
For all studies describing clinical trials, JBC adopts the ICMJE Recommendations for data sharing statement policy (http://icmje.org/icmje-recommendations.pdf). All manuscripts reporting clinical trial results should submit a data sharing statement following the ICMJE guidelines from October 1, 2018.
Source ↗Publisher website ·- License & copyright 5. Copyright
All published papers are under Creative Commons licenses and the authors retain the copyright. By submitting your manuscript to JBC, you agree to have the CC BY NC license applied to your work. This allows anyone to read, copy, distribute, or reuse the content non-commercially, as long as the author of the original work is cited.
Source ↗Publisher website ·- Open access 3. Open Access Policy
All research articles published in the JBC are fully open access, i.e., immediately and freely available to read, download, and share for non-commercial purposes. Any use of the Open Access version of JBC in whole or in part must include the customary bibliographic citation, including author and publisher attribution, date, article title, Journal of Breast Cancer, and the URL https://www.ejbc.kr/ …
Source ↗Publisher website ·- Peer review 1. Peer Review Process
All original articles, and most other articles, submitted to JBC undergo a thorough peer-review process. All submissions to JBC are initially assessed by the Editor, who determines their suitability for external peer-review. After the initial assessment, JBC’s editorial office sends the manuscript to two or three peer reviewers in the corresponding field. Once the reviewer accepts our invitation t…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Korean Breast Cancer Society
- Country or region
- SOUTH KOREA
- Language
- English, Korean
- Frequency
- Quarterly
- Founded
- 2003
- ISSN
- 1738-6756
- Electronic ISSN
- 2092-9900
- Latest issue on the website
- Volume 29, Issue 4 (August 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
FAQ
Frequently asked questions about Journal of Breast Cancer
What CAS zone is Journal of Breast Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Breast Cancer is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Breast Cancer?
The latest impact factor listed by LetPub is 3.67; CiteScore 4.7, h-index 64.
How long does peer review take at Journal of Breast Cancer?
Based on the dates recorded on 76 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 129 days (interquartile range 93–163 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Breast Cancer?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: ≤ 5; Manuscript length: ≤ 4,000 words; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Breast Cancer based?
Of the 52 board members whose country the journal's board page names, none are in mainland China; the countries named most often are South Korea (49), Japan (2) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Breast Cancer?
According to LetPub and DOAJ records, Journal of Breast Cancer is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, PMC, PubMed and Embase; that list has not been checked against each database.
Is Journal of Breast Cancer open access, and what is the APC?
Journal of Breast Cancer is a fully open-access journal. APC about USD 500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .